Chris Twelves

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Peter A. Kaufman, Ahmad Awada, Chris Twelves et al. · Journal of Clinical Oncology · 2015 · 442 citations · Full text

Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine

Javier Cortés, Linda T. Vahdat, Joanne L. Blum et al. · Journal of Clinical Oncology · 2010 · 215 citations

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

Chris Twelves, Javier Cortés, Linda T. Vahdat et al. · Breast Cancer Research and Treatment · 2014 · 205 citations · Full text

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Peter Barrett‐Lee, Lindsay Johnson, David Cameron et al. · The Lancet · 2009 · 188 citations · Full text

Breast Oncology, Oncology, Phase Iii +9

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials

Thierry Gorlia, Roger Stupp, Alba A. Brandes et al. · European Journal of Cancer · 2012 · 185 citations

Neuro-oncology, Prognostic Evaluation, Medicine +11